Scientists study degradation of toxic compound found in groundwater systems

NewsGuard 100/100 Score

Vinyl chloride is a cancer-causing compound formed from solvents in groundwater systems under anaerobic conditions. These solvents are used in many industrial applications around the world and often belong to the most encountered groundwater pollutants in industrialized countries. Groundwater is a major drinking water resource, and it is vital to determine if vinyl chloride can be further degraded into harmless compounds.

A group of scientists at Ecole Polytechnique F-d-rale de Lausannne (EPFL) and the University of Neuch-tel, Switzerland, has studied the degradation of the toxic compound in a laboratory setting mimicking a natural groundwater system. This work has been funded by the Swiss Federal Office for Education and Science within the framework of the EC Environment/Water Program.

In this experiment, solutions containing vinyl chloride, as well as some mineral salts, were pumped through laboratory columns. The toxic compound was regularly analyzed in inlet and outlet samples. After several weeks of cycling, vinyl chloride concentrations began to decrease, reaching zero after about four months. Ethene, an organic compound often used as a plant hormone, is one of the possible degradation products.

Christof Holliger, Director of the EPFL laboratory, explained that ethene's outlet concentration was always lower than the inlet vinyl chloride concentration.

The complete results from this study were published in the May-June 2011 issue of Journal of Environmental Quality.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
U-M research offers a new path forward in the development of anti-HIV drugs